Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov 7;8(1):264.
doi: 10.1186/s13643-019-1188-0.

How should systematic reviewers handle conference abstracts? A view from the trenches

Affiliations

How should systematic reviewers handle conference abstracts? A view from the trenches

Roberta W Scherer et al. Syst Rev. .

Abstract

Background: While identifying and cataloging unpublished studies from conference proceedings is generally recognized as a good practice during systematic reviews, controversy remains whether to include study results that are reported in conference abstracts. Existing guidelines provide conflicting recommendations.

Main body: The main argument for including conference abstracts in systematic reviews is that abstracts with positive results are preferentially published, and published sooner, as full-length articles compared with other abstracts. Arguments against including conference abstracts are that (1) searching for abstracts is resource-intensive, (2) abstracts may not contain adequate information, and (3) the information in abstracts may not be dependable. However, studies comparing conference abstracts and fully published articles of the same study find only minor differences, usually with conference abstracts presenting preliminary results. Other studies that have examined differences in treatment estimates of meta-analyses with and without conference abstracts report changes in precision, but usually not in the treatment effect estimate. However, in some cases, including conference abstracts has made a difference in the estimate of the treatment effect, not just its precision. Instead of arbitrarily deciding to include or exclude conference abstracts in systematic reviews, we suggest that systematic reviewers should consider the availability of evidence informing the review. If available evidence is sparse or conflicting, it may be worthwhile to search for conference abstracts. Further, attempts to contact authors of abstracts or search for protocols or trial registers to supplement the information presented in conference abstracts is prudent. If unique information from conference abstracts is included in a meta-analysis, a sensitivity analysis with and without the unique results should be conducted.

Conclusions: Under given circumstances, it is worthwhile to search for and include results from conference abstracts in systematic reviews.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Flow chart showing our suggestions for how to approach the use of conference abstracts in systematic review

References

    1. Balshem H, Stevens A, Ansari M, Norris S, Kansagara D, Shamliyan Try, et al. Finding Grey Literature Evidence and Assessing for Outcome and Analysis Reporting Biases When Comparing Medical Interventions: AHRQ and the Effective Health Care Program. Methods Guide for Comparative Effectiveness Reviews [Internet]. Rockville: Agency for Healthcare Research and Quality (US): 2008-AHRQ Methods for Effective Health Care. 2013. - PubMed
    1. (IOM) IoM . Knowing what works in health care: a roadmap for the nation. Washington, D. C: The National Academies Press; 2008.
    1. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. The Cochrane Collaboration 2011.
    1. Scherer RW, Meerpohl JJ, Pfeifer N, Schmucker C, Schwarzer G, von Elm E. Full publication of results initially presented in abstracts. Cochrane Database of Syst Rev. 2018;11:Mr000005. - PMC - PubMed
    1. Antes G, Chalmers I. Under-reporting of clinical trials is unethical. Lancet. 2003;361:978–979. doi: 10.1016/S0140-6736(03)12838-3. - DOI - PubMed

LinkOut - more resources